Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hyperpigmentation disorders
ADR ID BADD_A02139
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.05      Pigmentation disorders
23.05.01      Hyperpigmentation disorders
Description Not Available
MedDRA Code 10020713
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D000022-hydroxy-3-phenylpropanoic acid--
BADD_D00033Acetylsalicylic acid0.000022%
BADD_D00048Aflibercept--
BADD_D00052Albendazole0.001691%
BADD_D00066Alendronic acid0.000066%
BADD_D00075Alitretinoin--
BADD_D00103Amikacin0.000228%
BADD_D00110Aminolevulinic acid--
BADD_D00111Aminolevulinic acid hydrochloride--
BADD_D00121Amlodipine--
BADD_D00129Amoxicillin0.000005%
BADD_D00156Apremilast0.003810%
BADD_D00168Arsenic--
BADD_D00169Arsenic trioxide--
BADD_D00178Atenolol0.000019%
BADD_D00195Azathioprine0.000470%
BADD_D00260Betamethasone--
BADD_D00271Bicalutamide0.001406%
BADD_D00274Bimatoprost0.006926%
BADD_D00277Bisoprolol--
BADD_D00280Bleomycin--
BADD_D00281Bleomycin sulfate--
BADD_D00284Bortezomib0.000246%
BADD_D00294Brimonidine--
BADD_D00318Busulfan--
BADD_D00334Calcipotriene--
BADD_D00349Capecitabine0.003212%
BADD_D00356Carbamazepine0.000465%
BADD_D00364Carboplatin0.000168%
BADD_D00371Carmustine--
The 1th Page    1 2 3 4 5    Next   Last    Total 8 Pages
ADReCS-Target
ADR Term Drug Name Target